pharmaceutical-technology.com
71%
657
Russia’s RDIF, ChemRar to boost production of Avifavir for Covid-19
Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.A joint venture established by the Russian Direct Investment Fund (RDIF) and ChemRar Group is set to boost production of Avifavir, which secured temporary approval from the Russian government to treat Covid-19. Avifavir is a generic version of an anti-flu drug, Avigan (favipiravir), which has been used in Japan since 2014 to treat severe forms of influenza.